Skip to content

Women's health guide

Women's Health Supplements: Hormones, Inositol, and Iron

Front labels promising total hormonal balance exploit real endocrine symptoms with vague blends, but substantive nutritional support requires validated forms and clinical doses of inositols, bioactive folates, and chelated minerals. FTC health products compliance guidance Unfer et al. 2012 review on myo-inositol and D-chiro-inositol 40:1 ratio in PCOS

Last reviewed: 2026-10-07Focus: women's health, inositol 40:1 ratio, 5-MTHF folate, iron bisglycinate, chasteberry

The quick read

The myth of the all-in-one hormone balance supplement

The dietary supplement industry heavily markets products claiming to balance female hormones, optimize metabolism, and resolve PMS in a single scoop or pill pack. However, endocrinology recognizes no single state called hormonal balance. Female reproductive physiology involves intricate, cyclical fluctuations of estrogens, progesterone, luteinizing hormone, follicle-stimulating hormone, and insulin. Marketing language that treats diverse endocrine pathways as a single dial obscures what a formula actually does. FTC health products compliance guidance FDA dietary supplement labeling guide

Vague hormonal claims often bundle subtherapeutic doses of dozens of herbs into proprietary blends. If a formula hides behind a feminine wellness complex, consumers cannot verify whether active botanicals or nutrients reach levels tested in clinical trials. Reliable supplementation requires isolating specific biological objectives, identifying the exact chemical forms on the Supplement Facts panel, and matching doses to published human literature. FDA dietary supplement labeling guide FTC health products compliance guidance

Inositols: the physiological 40:1 ratio for metabolic support

Inositol is a carbocyclic sugar that serves as a secondary messenger for insulin signaling and gonadotropin-mediated ovarian follicle growth. In healthy women, the body maintains a strict ratio of approximately 40 parts myo-inositol (MI) to one part D-chiro-inositol (DCI) in plasma. Myo-inositol promotes cellular glucose uptake and follicle-stimulating hormone signaling, while D-chiro-inositol participates in insulin-mediated glycogen synthesis. Unfer et al. 2012 review on myo-inositol and D-chiro-inositol 40:1 ratio in PCOS

Clinical research led by Unfer and international consensus panels demonstrate that supplementing with 2,000 to 4,000 mg of myo-inositol combined with 50 to 100 mg of D-chiro-inositol (maintaining the 40:1 ratio) improves ovulatory regularity, insulin sensitivity, and androgen levels in women with metabolic challenges. Products that supply unbalanced ratios, such as high-dose D-chiro-inositol alone, can impair oocyte quality and counteract therapeutic benefits. Unfer et al. 2012 review on myo-inositol and D-chiro-inositol 40:1 ratio in PCOS

Bioavailable folate: 5-MTHF versus synthetic folic acid

Folate is an essential water-soluble B-vitamin required for DNA synthesis, methylation pathways, and embryonic neural tube development. While conventional supplements use oxidized synthetic folic acid, the body must convert folic acid through multiple enzymatic steps, including dihydrofolate reductase (DHFR) and methylenetetrahydrofolate reductase (MTHFR), into biologically active (6S)-5-methyltetrahydrofolate (5-MTHF). Scaglione and Panzavolta 2014 review of folate, folic acid, and 5-MTHF NIH ODS folate fact sheet

Common genetic polymorphisms in the MTHFR gene significantly reduce the rate of enzymatic conversion, leaving unmetabolized folic acid in circulation when taken at high doses. Supplementing directly with calcium or glucosamine salts of L-5-methyltetrahydrofolate bypasses these genetic bottlenecks, delivering pre-activated folate directly to peripheral tissues. Checking for 5-MTHF or methylfolate on the panel ensures bioavailable folate intake regardless of genetic profile. Scaglione and Panzavolta 2014 review of folate, folic acid, and 5-MTHF NIH ODS folate fact sheet

Iron: bisglycinate chelate versus harsh ferrous salts

Iron deficiency remains the most widespread nutritional deficiency among premenopausal women due to monthly menstrual blood loss. Yet traditional iron supplements rely on inorganic ferrous sulfate, ferrous fumarate, or ferrous gluconate. In a meta-analysis published in PLOS ONE by Tolkien and colleagues, oral ferrous sulfate caused gastrointestinal adverse effects in over 30 percent of patients, predominantly nausea, constipation, and abdominal cramping. Tolkien et al. 2015 meta-analysis of ferrous sulfate gastrointestinal adverse events NIH ODS iron fact sheet

In contrast, ferrous bisglycinate binds an iron atom to two glycine amino acids, forming a stable neutral chelate that resists gastric breakdown and avoids irritating the intestinal mucosa. Clinical trials indicate that iron bisglycinate offers superior absorption rates, allowing lower elemental iron doses (typically 18 to 27 mg) to restore ferritin levels with substantially fewer digestive side effects. Tolkien et al. 2015 meta-analysis of ferrous sulfate gastrointestinal adverse events NIH ODS iron fact sheet

Botanical boundaries and clinical safety

Herbal ingredients frequently marketed for PMS and cycle regularity require careful clinical boundaries. Vitex agnus-castus (chasteberry) exerts dopaminergic effects on the anterior pituitary, suppressing prolactin secretion and altering luteal phase progesterone. NCCIH cautions that chasteberry should not be consumed during pregnancy, breastfeeding, or alongside hormonal contraceptives, fertility medications, or dopamine agonists. NCCIH chasteberry NCCIH using dietary supplements wisely

Similarly, black cohosh, red clover, and adaptogens carry complex interactions with hepatic enzymes and estrogen-sensitive tissues. The National Center for Complementary and Integrative Health emphasizes that dietary supplements cannot treat medical endocrine pathologies like polycystic ovary syndrome, endometriosis, or premature ovarian failure. Suspected hormonal disorders require formal diagnostic evaluation, including serum hormone and ferritin panels, by a qualified reproductive endocrinologist or gynecologist. NCCIH menopause and complementary health NCCIH using dietary supplements wisely

Evidence-based dosages, optimal molecular forms, and physiological targets for key women's health nutrients.
Nutrient / CompoundPhysiological TargetClinical Evidence DosageOptimal Chemical Form
Inositols (MI : DCI)Insulin signaling and ovulatory regularity4,000 mg MI + 100 mg DCI (40:1 ratio)Myo-inositol + D-chiro-inositol powder
FolateCellular methylation and neural tube support400-800 mcg DFE dailyL-5-methyltetrahydrofolate (5-MTHF)
IronHemoglobin synthesis and ferritin restoration18-27 mg elemental ironFerrous bisglycinate chelate
Chasteberry (Vitex)Dopaminergic prolactin modulation for PMS20-40 mg standardized fruit extractStandardized agnuside or casticin extract

Table sources: Unfer et al. 2012 review on myo-inositol and D-chiro-inositol 40:1 ratio in PCOS Scaglione and Panzavolta 2014 review of folate, folic acid, and 5-MTHF Tolkien et al. 2015 meta-analysis of ferrous sulfate gastrointestinal adverse events NCCIH chasteberry

What to check on the label

Verify the 40:1 inositol ratio

Check that inositol formulas supply myo-inositol and D-chiro-inositol in the physiological 40:1 ratio rather than unstandardized or isolated DCI. Unfer et al. 2012 review on myo-inositol and D-chiro-inositol 40:1 ratio in PCOS FDA dietary supplement labeling guide

Choose active 5-MTHF folate

Select L-methylfolate rather than synthetic folic acid to ensure direct cellular utilization regardless of MTHFR enzyme efficiency. Scaglione and Panzavolta 2014 review of folate, folic acid, and 5-MTHF NIH ODS folate fact sheet

Opt for chelated iron bisglycinate

Prioritize ferrous bisglycinate chelate over ferrous sulfate to minimize constipation, abdominal distress, and gastric mucosal irritation. Tolkien et al. 2015 meta-analysis of ferrous sulfate gastrointestinal adverse events NIH ODS iron fact sheet

Screen Vitex for interactions

Avoid chasteberry during pregnancy, nursing, or while taking oral contraceptives or fertility medications due to pituitary-dopaminergic activity. NCCIH chasteberry NCCIH using dietary supplements wisely

Base intake on lab diagnostics

Verify iron and hormone status through serum ferritin, CBC, and endocrine testing before initiating high-dose targeted supplementation. NIH ODS iron fact sheet NCCIH using dietary supplements wisely

Sources

  1. Unfer et al. 2012 review on myo-inositol and D-chiro-inositol 40:1 ratio in PCOS: https://pubmed.ncbi.nlm.nih.gov/23078456/
  2. Scaglione and Panzavolta 2014 review of folate, folic acid, and 5-MTHF: https://pmc.ncbi.nlm.nih.gov/articles/PMC4161865/
  3. Tolkien et al. 2015 meta-analysis of ferrous sulfate gastrointestinal adverse events: https://pmc.ncbi.nlm.nih.gov/articles/PMC4336295/
  4. NIH ODS iron fact sheet: https://ods.od.nih.gov/factsheets/Iron-Consumer/
  5. NIH ODS folate fact sheet: https://ods.od.nih.gov/factsheets/Folate-Consumer/
  6. NCCIH chasteberry: https://www.nccih.nih.gov/health/chasteberry
  7. NCCIH menopause and complementary health: https://www.nccih.nih.gov/health/menopausal-symptoms-in-depth
  8. NCCIH using dietary supplements wisely: https://www.nccih.nih.gov/health/using-dietary-supplements-wisely
  9. FDA dietary supplement labeling guide: https://www.fda.gov/food/dietary-supplements-guidance-documents-regulatory-information/dietary-supplement-labeling-guide-chapter-iv-nutrition-labeling
  10. FTC health products compliance guidance: https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance

Keep reading

How this article was made

NutriScore has not commissioned independent clinical review of this article.

Read the editorial policy and scoring methodology. Sources favor primary canon, regulators, product labels, and peer-reviewed research; reputable secondary reporting is identified when used.

Corrections: send corrections or updated label/source evidence to support@nutriscore.fit or use the contact page.

Sources: 10 entries, primary canon plus reputable secondary sources with inline acknowledgment, last reviewed 2026-10-07.

For research and educational purposes only. Not medical advice.